Trial intelligence / Profile preview

Effect of different doses of esketamine on postoperative recovery quality in gynecological laparoscopic surgery

ChiCTR2400082718Phase 4Not yet recruiting

Sponsor
Second People's Hospital of Anhui Province
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in gynaecological conditions (3 arms), sponsored by Second People's Hospital of Anhui Province. Primary endpoint: postoperative quality of recovery score. Planned start Apr 2024; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

gynaecological conditions

Beyond the preview

Go deeper on ChiCTR2400082718.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400082718.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call